Lewis L Hsu
Overview
Explore the profile of Lewis L Hsu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
93
Citations
1853
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Principe D, Reilly P, Dhavamani S, Rivers A, Molokie R, Hsu L, et al.
J Pediatr Hematol Oncol
. 2024 Jun;
46(6):e457-e462.
PMID: 38934620
The clinical course for Hereditary Spherocytosis (HS) patients is highly varied, even within families with identical driving mutations. Here, we describe four siblings with HS attributed to an unreported SPTB...
2.
Davidow K, Miller R, Phillips S, Schlenz A, Mueller M, Hulbert M, et al.
Blood Adv
. 2024 Apr;
8(13):3444-3452.
PMID: 38669350
Children with sickle cell anemia (SCA) are at increased risk of stroke when compared with their age-based counterparts. The Stroke Prevention Trial in Sickle Cell Anemia (STOP) previously demonstrated that...
3.
Njoku F, Pugh N, Brambilla D, Kroner B, Shah N, Treadwell M, et al.
Am J Hematol
. 2024 Mar;
99(5):900-909.
PMID: 38450756
The cause of death in people affected by sickle cell disease (SCD) is often challenging to define as prior studies have used retrospective or administrative data for analysis. We used...
4.
Mendez G, Nocek J, Brambilla D, Jacobs S, Cole O, Kanter J, et al.
BMC Health Serv Res
. 2024 Mar;
24(1):291.
PMID: 38448911
Background: Adults with sickle cell disease (SCD) suffer early mortality and high morbidity. Many are not affiliated with SCD centers, defined as no ambulatory visit with a SCD specialist in...
5.
Girish G, Xiang B, Hsu L
Am J Case Rep
. 2023 Nov;
24:e941268.
PMID: 37990483
BACKGROUND Sickle cell disease is an inherited blood disorder that leads to multisystem complications. The heterogeneous course of sickle cell disease is due to both genetic modifiers and environmental factors....
6.
Baumann A, Hankins J, Hsu L, Gibson R, Richardson L, Treadwell M, et al.
BMC Health Serv Res
. 2023 Nov;
23(1):1245.
PMID: 37953236
Background: This study aimed to capture the implementation process of the ALIGN Study, (An individualized Pain Plan with Patient and Provider Access for Emergency Department care of Sickle Cell Disease)....
7.
Hankins J, Brambilla D, Potter M, Kutlar A, Gibson R, King A, et al.
Blood Adv
. 2023 Sep;
7(23):7190-7201.
PMID: 37738155
Hydroxyurea reduces sickle cell disease (SCD) complications, but medication adherence is low. We tested 2 mobile health (mHealth) interventions targeting determinants of low adherence among patients (InCharge Health) and low...
8.
9.
10.
Tabiti B, Ozawa S, Mian A, Suri M, Yates H, Hsu L
Hematol Oncol Stem Cell Ther
. 2023 Apr;
16(3):254-261.
PMID: 37023225
Sickle Cell Disease (SCD) is a hereditary blood disorder affecting beta hemoglobin. This disorder causes sickle-shaped red blood cells with decreased oxygen-carrying capacity resulting in vaso-occlusive crises. These crises are...